Factors influencing this expansion include: The growing prevalence of breast cancer plays ... Kadcyla is a targeted treatment that integrates the HER2-targeting antibody trastuzumab with the ...

An invasive, aggressive and fast-spreading breast cancer, which is affecting younger Indian women, may just get easier to treat. Researchers at Tata Memorial have found a hidden weak spot or an ...

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...

The FDA has started a priority review of Boehringer Ingelheim's small-molecule HER2 inhibitor zongertinib as a treatment for a form of lung cancer, setting up a decision later this year and giving ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...